These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32004823)

  • 1. Reversal of endothelial dysfunction post-immunosuppressive therapy in adult-onset podocytopathy and primary membranous nephropathy.
    Inamdar N; Tomer S; Kalmath S; Bansal A; Yadav AK; Sharma V; Bahuguna P; Gorsi U; Arora S; Lal A; Kumar V; Rathi M; Kohli HS; Gupta KL; Ramachandran R
    Atherosclerosis; 2020 Feb; 295():38-44. PubMed ID: 32004823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented mannose-binding lectin levels in primary membranous nephropathy: A pilot study.
    Pal D; Inamdar N; Kaur P; Singhal M; Lal A; Gorsi U; Nada R; Kohli HS; Kumar V; Ramachandran R
    Nephrology (Carlton); 2024 Sep; 29(9):617-621. PubMed ID: 38511256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunosuppressive Therapy in Primary Membranous Nephropathy with Compromised Renal Function.
    Ramachandran R; Prabakaran R; Priya G; Nayak S; Kumar P; Kumar A; Kumar V; Agrawal N; Rathi M; Kohli HS; Nada R
    Nephron; 2022; 146(2):138-145. PubMed ID: 34818240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressive treatment of idiopathic membranous glomerulonephritis with nephrotic syndrome].
    Muslimović A; Rasić S; Rebić D; Uncanin S
    Med Arh; 2009; 63(4):187-90. PubMed ID: 20088170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.
    Guo Y; Wu X; Liu L; Zhang H; Yang L; Chen W
    Ren Fail; 2020 Nov; 42(1):122-130. PubMed ID: 31957527
    [No Abstract]   [Full Text] [Related]  

  • 7. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome.
    Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G
    Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary N-acetyl-β-glucosaminidase and estimated Glomerular filtration rate may identify patients to be treated with immuno-suppression at diagnosis in idiopathic membranous nephropathy.
    Bazzi C; Usui T; Rizza V; Casellato D; Gallieni M; Nangaku M
    Nephrology (Carlton); 2018 Feb; 23(2):175-182. PubMed ID: 27764902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary membranous nephropathy in adolescence: A prospective study.
    Kumar V; Varma AK; Nada R; Ghosh R; Suri D; Gupta A; Kumar V; Rathi M; Kohli H; Jha V; Gupta K; Ramachandran R
    Nephrology (Carlton); 2017 Sep; 22(9):678-683. PubMed ID: 27334445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin resistance, dyslipidaemia, inflammation and endothelial function in nephrotic syndrome.
    Dogra GK; Herrmann S; Irish AB; Thomas MA; Watts GF
    Nephrol Dial Transplant; 2002 Dec; 17(12):2220-5. PubMed ID: 12454236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acthar gel in the treatment of nephrotic syndrome: a multicenter retrospective case series.
    Madan A; Mijovic-Das S; Stankovic A; Teehan G; Milward AS; Khastgir A
    BMC Nephrol; 2016 Mar; 17():37. PubMed ID: 27036111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction and long-term treatment with cyclosporine in membranous nephropathy with the nephrotic syndrome.
    Alexopoulos E; Papagianni A; Tsamelashvili M; Leontsini M; Memmos D
    Nephrol Dial Transplant; 2006 Nov; 21(11):3127-32. PubMed ID: 16968719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction model for treatment response of primary membranous nephropathy with nephrotic syndrome.
    Li M; Lai X; Liu J; Yu Y; Li X; Liu X
    Clin Exp Nephrol; 2024 Aug; 28(8):740-750. PubMed ID: 38709377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of immunosuppressive therapeutic regimens in patients with nephrotic syndrome due to idiopathic membranous nephropathy.
    Kosmadakis G; Filiopoulos V; Smirloglou D; Skarlas P; Georgoulias C; Michail S
    Ren Fail; 2010 Jun; 32(5):566-71. PubMed ID: 20486839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G; Filiopoulos V; Georgoulias C; Tentolouris N; Michail S
    Scand J Urol Nephrol; 2010 Sep; 44(4):251-6. PubMed ID: 20201749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q; Li H; Xie X; Qu F; Li X; Chen J
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into immune mechanisms underlying response to Rituximab in patients with membranous nephropathy: A prospective study and a review of the literature.
    Roccatello D; Sciascia S; Di Simone D; Solfietti L; Naretto C; Fenoglio R; Baldovino S; Menegatti E
    Autoimmun Rev; 2016 Jun; 15(6):529-38. PubMed ID: 26876383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimal blood pressure control versus additional immunosuppressive therapy in idiopathic membranous nephropathy - a retrospective analysis.
    Dikow R; Quentmeier P; Schwenger V; Waldherr R; Andrassy K; Ritz E; Zeier M
    Clin Nephrol; 2009 Nov; 72(5):366-72. PubMed ID: 19863879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Schieppati A; Perna A; Zamora J; Giuliano GA; Braun N; Remuzzi G
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004293. PubMed ID: 15495098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of belimumab on proteinuria and anti-phospholipase A2 receptor autoantibody in primary membranous nephropathy.
    Barrett C; Willcocks LC; Jones RB; Tarzi RM; Henderson RB; Cai G; Gisbert SI; Belson AS; Savage CO
    Nephrol Dial Transplant; 2020 Apr; 35(4):599-606. PubMed ID: 31243451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.